Phosphoric Acid

Phosphoric Acid

SCHEMBL45358

O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.56
SLC34A1 Q06495 1/20 0.50
FDPS P14324 2/20 0.46
BLM P54132 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
KDM4E B2RXH2 2/20 0.46
MMP2 P08253 2/20 0.46
THRB P10828 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TYMS P04818 1/20 0.39
LMNA P02545 2/20 0.36
KMT2A Q03164 2/20 0.33
PGK1 P00558 2/20 0.33
PGK2 P07205 2/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CA4 P22748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL9126 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL8851940 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL140393 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL1332284 1.00
Phosphoric Acid SCHEMBL897840 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL22 1.00
Phosphoric Acid SCHEMBL8844890 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL3788505 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL5907 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1
Phosphoric Acid SCHEMBL36090 1.00 CA2 (0.56) CA2SLC34A1FDPSBLMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2603 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3244473-B1 METHOD FOR PREPARING BATTERY COMPOSITE MATERIAL AND PRECURSOR THEREOF ADVANCED LITHIUM ELECTROCHEMISTRY CO LTD (TW) 2024-06-26 EP claimed
CN-118109807-A Aerosol for forming compact protective layer on surface of metal piece 浙江绿岛科技有限公司 2024-05-31 CN claimed
EP-4363392-A1 PERFORMANCE ENHANCER FOR COMPOSITE CEMENTS Heidelberg Materials AG (DE) 2024-05-08 EP claimed
EP-3880190-B1 ANTICANCER COMPOSITION COMPRISING A BIGUANIDE, 2-DEOXY-GLUCOSE AND AN INOSITOL NOAHM INC (KR) 2024-04-10 EP claimed
WO-2024058659-A1 PLANT FIBRE PRODUCT BEYONDWOOD B.V. (NL) 2024-03-21 WO claimed
US-20240042036-A1 ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF FENNEC PHARMACEUTICALS INC (US) 2024-02-08 US claimed
CN-117186256-A Toughened starch-based single-component intumescent flame retardant as well as preparation method and application thereof 福州大学 2023-12-08 CN claimed
CN-117100881-A radiopharmaceutical composition 郑州原子高科医药有限公司 2023-11-24 CN claimed
CN-112566895-B Cleavable linkers for peptide synthesis 豪夫迈·罗氏有限公司 2023-10-20 CN claimed
WO-2023193892-A1 NUCLEIC ACID COMPOSITIONS COMPRISING AN INORGANIC POLYPHOSPHATE AND METHODS FOR PREPARING, STORING AND USING THE SAME BioNTech SE (DE) 2023-10-12 WO claimed
EP-1005327-A1 TARGETED LIPOSOMAL CONSTRUCTS FOR DIAGNOSTIC AND THERAPEUTIC USES SDG, INC. (US) 2000-06-07 EP claimed
US-6063400-A CARRIER; DIAGNOSTIC OR THERAPEUTIC AGENT AND SEQUESTERING AGENT SDG, INC. (US) 2000-05-16 US claimed
EP-0615747-B1 Hemoglobin-encapsulating liposome and method for making the same TERUMO CORP (JP) 1999-09-29 EP claimed
WO-1999001110-A1 TARGETED LIPOSOMAL CONSTRUCTS FOR DIAGNOSTIC AND THERAPEUTIC USES SDG, INC. (US) 1999-01-14 WO claimed
US-5827837-A Polyanion anti-inflammatory agents THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-10-27 US claimed
US-5260287-A Phosphorylated alcohols and polyvalent cations used as antiulcer agents BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 1993-11-09 US claimed
EP-0101341-B1 PROCESS AND DEVICE FOR THE ENCAPSULATION IN ERYTHROCYTES OF AT LEAST ONE BIOLOGICALLY ACTIVE SUBSTANCE, IN PARTICULAR HEMOGLOBIN ALLOSTERIC EFFECTORS, AND ERYTHROCYTES SO OBTAINED Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1986-11-05 EP claimed
EP-0101341-A1 Process and device for the encapsulation in erythrocytes of at least one biologically active substance, in particular hemoglobin allosteric effectors, and erythrocytes so obtained Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1984-02-22 EP claimed
US-4391607-A Dyeing process and printing process using reactive dyestuffs BAYER AKTIENGESELLSCHAFT (DE) 1983-07-05 US claimed
EP-0001104-B1 MODIFIED INTACT ERYTHROCYTES, BLOOD OR BLOOD PRESERVES CONTAINING THEM AND PROCESS FOR THEIR PREPARATION Studiengesellschaft Kohle mbH (DE) 1981-05-20 EP claimed